Fehintola F A, Balogun S T
Department of Pharmacology and Therapeutics, College of Medicine, University of Ibadan, Ibadan.
J Vector Borne Dis. 2010 Sep;47(3):145-50.
BACKGROUND & OBJECTIVES: The study was undertaken to evaluate the efficacy of cotrimoxazole plus artesunate and to compare the efficacy of this combination with that of artesunate plus chloroquine in the treatment of acute uncomplicated falciparum malaria in children.
Children aged between 0.5 and 12 yr with clinical and parasitological evidence of Plasmodium falciparum malaria were randomized to receive either artesunate plus cotrimoxazole or artesunate plus chloroquine. They were followed-up with clinical and parasitological assessment for a period of 14 days.
In all, 57 out of 81 (31 in the artesunate plus cotrimoxazole group and 26 in artesunate plus chloroquine group) completed the study as per protocol and were evaluated. Pre-treatment clinical and parasitological parameters were similar in the two treatment groups. The time to clear fever and other symptoms were similar in the two groups 1.0 +/- 0 vs 1.14 +/- 0.38 (p > 0.05). Parasite clearance times were also similar; 1.65 +/- 0.49 days vs 1.58 +/- 0.67 days respectively for artesunate plus cotrimoxazole and artesunate plus chloroquine (p > 0.05). The cure rates on Day 14 were 100% for both artesunate plus cotrimoxazole and artesunate plus chloroquine groups. Both drug combinations were well-tolerated in the small population of children.
These results indicate that artesunate plus cotrimoxazole has similar efficacy to artesunate plus chloroquine in the treatment of acute uncomplicated P. falciparum malaria in children resident in an endemic area of south-west Nigeria.
本研究旨在评估复方新诺明联合青蒿琥酯的疗效,并比较该联合用药与青蒿琥酯联合氯喹治疗儿童急性非复杂性恶性疟的疗效。
年龄在0.5至12岁之间、有恶性疟原虫疟疾临床及寄生虫学证据的儿童被随机分为两组,分别接受青蒿琥酯联合复方新诺明或青蒿琥酯联合氯喹治疗。对他们进行为期14天的临床及寄生虫学随访评估。
总共81名儿童中,有57名(青蒿琥酯联合复方新诺明组31名,青蒿琥酯联合氯喹组26名)按方案完成研究并接受评估。两个治疗组治疗前的临床及寄生虫学参数相似。两组退热及其他症状消失时间相似,分别为1.0±0天和1.14±0.38天(p>0.05)。寄生虫清除时间也相似,青蒿琥酯联合复方新诺明组和青蒿琥酯联合氯喹组分别为1.65±0.49天和1.58±0.67天(p>0.05)。第14天的治愈率在青蒿琥酯联合复方新诺明组和青蒿琥酯联合氯喹组均为100%。在这一小群儿童中,两种药物组合耐受性均良好。
这些结果表明,在治疗尼日利亚西南部疟疾流行地区儿童的急性非复杂性恶性疟方面,青蒿琥酯联合复方新诺明与青蒿琥酯联合氯喹疗效相似。